November 14, 2019
Focused program of partnerships, collaboration, funding and volunteering addresses the community-level prevention, diagnosis and treatment of a disease that takes the lives of around 800,000 under-five-year-olds each year, mostly in disadvantaged communities.
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and the Philips Foundation, with its mission to reduce healthcare inequality by providing access to quality healthcare for disadvantaged communities, today announced the achievements of a year-long program of collaborations to reduce infant mortality rates for childhood pneumonia, a disease that currently claims the lives of around 800,000 under-five-year-olds a year  – equivalent to one every 39 seconds.
Combining the volunteering activities of Philips’ 80,000 employees, local stakeholder engagement, accessible and affordable technology, and the scale-up capabilities of international NGOs, this childhood pneumonia program exemplifies the Philips Foundation’s commitment to drive and support initiatives that deliver long-term system change and achieve lasting impact. During the past 12 months, the program is estimated to have created access to better care for more than 700,000 people, in countries as widespread as Afghanistan, Ethiopia, Nicaragua, Malawi and India.
“The mission of the Philips Foundation is to reduce healthcare inequality by providing access to quality healthcare for disadvantaged communities,” said Ronald de Jong, Chairman of the Philips Foundation Board. “Focusing our year-long volunteering efforts on a single global healthcare issue that disproportionately affects disadvantaged communities, created a multiplier effect, supporting ways to overcome the challenges, and ensuring long-term impact.”
Pneumonia in children under five was chosen as the 2018-2019 topic for Philips’ employee volunteering, due to its many casualties, and the fact that respiratory disease is one of the expert fields of Philips that the foundation can tap into. Caused by viral, bacterial, or fungal infection of the lungs, childhood pneumonia can be prevented by immunization, a healthier diet and improved environmental conditions  – for example, better (indoor) air quality. Although bacterial pneumonia can be effectively treated with low-cost antibiotics, only a third of children receive them in time . The accurate determination of rapid breathing, which is the principal early indicator of childhood pneumonia, can be achieved by leveraging the power of artificial intelligence (AI) in affordable diagnostic devices.
Examples of the supported and initiated activities of the Philips Foundation over the past 12 months, conducted through global partnerships, local projects and support of social entrepreneurs, are listed below:
- Save the Children and ZMQ in India – VISHWAAS (Breath of Hope) project: This program is aimed at developing and proving a low-cost innovative approach in India for the prevention, diagnosis and treatment of childhood pneumonia, including an app-based solution to improve awareness of the means of prevention and care-seeking practices in affected communities.
- Partnership with Ashoka Fellow Hilmi Quraishi, ZMQ – the MIRA Channel project on childhood pneumonia: This project addresses the knowledge gap in childhood pneumonia through a series of short digital stories embedded in a larger ‘Maternal & Child Health’ mobile-based platform called MIRA.
- The Malaria Consortium BREATHE (Breath REcognition Aid to Health Experts) project: This study aims to assess the reliability of a video annotation tool for counting respiratory rate, which has the potential to be used as a new reference standard for measuring the performance of new automated respiratory rate diagnostic aids to support the diagnosis of pneumonia in children under five in low resource settings.
For further information, please contact:
Philips Global Press Office
Tel.: +31 6 15213446
Tel. : +31 6 18526633
About the Philips Foundation
The Philips Foundation is a registered charity that was established in July 2014 as the central platform for Philips’ CSR activities. Reflecting our commitment to United Nations Sustainable Development Goals 3 (Ensure healthy lives and promote well-being for all at all ages) and 17 (Revitalize the global partnership for sustainable development), the mission of the Foundation is to reduce healthcare inequality by providing access to quality healthcare for disadvantaged communities. We do this by deploying Philips’ expertise, innovative products and solutions, by collaborating with key partners around the world and by providing financial support for collaborative activities. More information on the Philips Foundation can be found at www.philips-foundation.com.
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips’ health technology portfolio generated 2018 sales of EUR 18.1 billion and employs approximately 80,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.